Navigation Links
Eleme Medical Announces The Real Women of SmoothShapes(R) Campaign
Date:1/13/2010

MERRIMACK, N.H., Jan. 13 /PRNewswire/ -- Eleme Medical Inc., premier aesthetics company and leader in the body shaping market, announced today that they will be conducting a global contest to select cellulite patients to be The Real Women of SmoothShapes. An alternative to celebrity endorsement, the campaign's objective is to promote the most preeminent success stories from real women who experienced SmoothShapes cellulite and BodySlimming™ treatments, letting the results speak for themselves so that people can relate to them – and the treatment – better.

"We couldn't be more excited to kick off The Real Women of SmoothShapes campaign," says Nancy M. Briefs, President and CEO of Eleme Medical. "Having real women openly share their experience receiving a SmoothShapes treatment and the effect on their self esteem and confidence is the best validation any product can achieve. Between 85 – 95 percent of women develop cellulite, and unfortunately diet and exercise are not enough. SmoothShapes is the quintessential treatment for real women seeking longer lasting results."

Contest winners will receive a complimentary series of treatments from a top physician in select areas, along with the opportunity to appear at media events and top aesthetic conferences where they can share their personal SmoothShapes experience.

"SmoothShapes is an affordable morale booster for all women, not just celebrities," said Jeana Keough, former cast member of Bravo's hit reality television show, The Real Housewives of Orange County. "Like most women, my body altered after giving birth to my three beautiful children. SmoothShapes was the best-confidence booster for me, as I no longer feel insecure when wearing certain types of fabric. The treatment is affordable, painless and shows remarkable improv
'/>"/>

SOURCE Eleme Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. AMD Global Telemedicine, Inc. Launches New Website
2. The ZigBee Alliance and the American Telemedicine Association to Collaborate on Advancing Use of Telehealth Solutions
3. AMD Global Telemedicine, Inc. Acquires Distribution Rights for AFHCAN's tConsult Telehealth Systems
4. Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army
5. AiRISTA's Unified Visibility Solutions Bringing Together Wi-Fi RTLS, And Telemetry Offer Enormous Business Opportunities To Systems Integrators
6. Bioelements Selects Room 214 as Their Social Media and Online Marketing Agency
7. Global Health Trax, Inc. Announces New Marketing Campaign for Oxygen Elements Max Product
8. New Report Just Published: World Telemedicine Market Report
9. e-Telmed, Inc., the First Complete Telemedicine Solution Provider, Selects TransMedia Group as their PR Firm
10. Nationwide telemedicine networks are essential for successful health care reform
11. Telemedicine expands reach of care for Parkinsons patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... quite common for a female song sparrow to stray ... next door, but a new study shows that sleeping ... is reported in The American Naturalist, found ... to have lower reproductive success than within-pair offspring. The ... ostensibly monogamous animals might be inclined to cheat. , ...
(Date:5/22/2012)... Health Sciences (NIEHS), part of the National Institutes of ... (SRP) at the University of California, San Diego. Over ... fund continued research on the molecular and genetic consequences ... hazardous waste sites. , It is the third funding ... funded by the NIEHS in 2000. , "The ...
(Date:5/22/2012)... Maureen Salamon HealthDay Reporter , , MONDAY, ... anticipated move sure to unleash heated debate, a ... men of all ages no longer be screened ... (PSA) blood test. The U.S. Preventive Services ... in prevention and evidence-based medicine, said PSA screening ...
(Date:5/22/2012)... 22 (HealthDay News) -- Hundreds of thousands of ... develop potentially life-threatening liver complications over the next ... Researchers evaluated medical insurance claims data and found ... advanced liver disease in 2008, and estimated that ... by 2015. The risk of developing advanced ...
(Date:5/22/2012)... thousands of psychiatrists attend their field,s largest annual meeting ... drug treatments report overwhelmingly on positive results. , ... the Journal of Clinical Psychopharmacology by two ... University, who analyzed the presentations given at two recent ... 278 studies presented at the 2009 and 2010 APA ...
Breaking Medicine News(10 mins):Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3
... ATLANTA, Jan. 7 The TV Teacher, LLC(TM) announces ... select,New York City schools: Queens, Bronx, and Staten Island. ... Alphabet Beats(TM) was co-created,by Susan Ellis, a mother struggling ... write the alphabet. After an unsuccessful two years ...
... B. Snow Jr., chairman and chief executive officer, Medco Health ... address the 27th Annual JPMorgan Healthcare Conference in San Francisco ... Francis Hotel, San Francisco, will begin at 8:30 a.m. PST ... are Richard J. Rubino, chief financial officer, and Robert S. ...
... 7 Boston Scientific Corporation (NYSE: BSX ... Morgan Health Care Conference in San Francisco.Jim Tobin, Chief ... January 14th, beginning at approximately 12:00 p.m. E.T. ... Chief Financial Officer will join Mr. Tobin in a ...
... Office (USPTO) has registered Guru Program® as a ... and honed by Tom Gable, of Gable PR, ... language said the mark covered: consulting services related ... and accounting services, health care, financial services, real ...
... 7 Agito Networks, Inc.(TM), the,company delivering ... today,announced that Technology Marketing Corporation,s (TMC(R)) Unified,Communications ... Networks,RoamAnywhere(TM) Mobility Router(TM) as a recipient of ... Agito Networks, award-winning RoamAnywhere ...
... and Telly Awards Honor CyberKnife Print and TV ... ARAY ), a global leader in ... has received three prestigious awards for its 2008 ... and RBG Marketing, who created the ads, received ...
Other Medicine News:Health News:New York Schools Receive Program for Children with Autism 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 2Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 3Health News:Accuray Receives Prestigious Awards for 2008 Advertising Campaign 4
(Date:5/22/2012)... Valeritas , the maker of V-Go™ Disposable Insulin ... the delivery of insulin designed especially for adults ... to support its state-of-the-art patient engagement program. ... people living with diabetes , and Valeritas ... management and support program designed to increase engagement ...
(Date:5/22/2012)... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an ... fight Human Immunodeficiency Virus (HIV) infections, today announced ... has opened enrollment for a Phase 1 trial ... vaccine is identical to the first ... except for the inclusion of granulocyte-macrophage colony-stimulating factor ...
(Date:5/22/2012)... 22, 2012  Eli Lilly and Company (NYSE: ... long-acting glucagon-like peptide 1 (GLP-1) analog being studied as ... primary endpoint of non-inferiority for mean 24-hour systolic blood ... 16 weeks. The results came from a Phase II ... using ambulatory blood pressure monitoring (ABPM) to characterize changes ...
Breaking Medicine Technology:Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 2Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 3Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting 4Study provides documentation that tumor stem like cells exist in benign tumors 52543 1Study provides documentation that tumor stem like cells exist in benign tumors 52543 2Study provides documentation that tumor stem like cells exist in benign tumors 52543 3Risky driving puts P platers at high danger of crash 52541 1Risky driving puts P platers at high danger of crash 52541 2Salt marshes 3A A natural and unnatural history 9327 1
... Society Conference, MONMOUTH JUNCTION, N.J., June 13 ... Phase II clinical trial on its lead,investigational drug, ... developed for the treatment of cystic fibrosis (CF),patients ... Pseudomonas,aeruginosa. The Phase II data indicated that Arikace, ...
... Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader in ... it has concluded enrollment and treated the last,patient ... AMT-011 (Glybera(R)) for,Hyperlipoproteinemia, a seriously debilitating and potentially ... countries,Germany and the United Kingdom of the European ...
Other Medicine Technology:Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 4Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections 5AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R)) 2AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R)) 3
... Siremobil Iso-C3D C-Arm imaging system interface sets ... mobile C-arm imaging. Combining mobility and ... the cooperative technologies deliver the most complete ... imaging is the new standard in the ...
... OmniSight image guided surgery system offers ... in design and use. It provides ... to localize critical anatomy and plan ... gives surgeons an easy-to-use, technologically advanced ...
... the next evolution in transforaminal lumbar interbody ... instruments.. The T.L.I.F. SG Instruments feature a ... preparation instruments designed to support the technically ... range of instrument options to meet the ...
The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
Medicine Products: